Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 276

2.

Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.

Heilbronn L, Smith SR, Ravussin E.

Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S12-21. Review.

PMID:
15592481
3.

Adipotoxicity and the insulin resistance syndrome.

Anderwald C, Roden M.

Pediatr Endocrinol Rev. 2004 Mar;1(3):310-9. Review.

PMID:
16437024
4.

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID:
16418758
5.
6.

Diabetes: insulin resistance and derangements in lipid metabolism. Cure through intervention in fat transport and storage.

Raz I, Eldor R, Cernea S, Shafrir E.

Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):3-14. Review.

PMID:
15386813
7.

[The role of the fat tissue and its hormones in the mechanisms of insulin resistance and the development of type 2 diabetes mellitus].

Klebanova EM, Balabolkin MI, Kreminskaia VM.

Klin Med (Mosk). 2007;85(7):20-7. Review. Russian.

PMID:
17882804
8.

Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.

de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF.

Diabetes. 2001 Aug;50(8):1863-71.

9.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

10.

Adipose tissue and the insulin resistance syndrome.

Frayn KN.

Proc Nutr Soc. 2001 Aug;60(3):375-80. Review.

PMID:
11681812
11.

Adipose tissue as an endocrine organ: impact on insulin resistance.

Jazet IM, Pijl H, Meinders AE.

Neth J Med. 2003 Jun;61(6):194-212. Review.

12.

Metabolic implications of dietary trans-fatty acids.

Dorfman SE, Laurent D, Gounarides JS, Li X, Mullarkey TL, Rocheford EC, Sari-Sarraf F, Hirsch EA, Hughes TE, Commerford SR.

Obesity (Silver Spring). 2009 Jun;17(6):1200-7. doi: 10.1038/oby.2008.662. Epub 2009 Feb 19. Erratum in: Obesity (Silver Spring). 2009 Jul;17(7):1474.

13.

Diabetes, lipids, and adipocyte secretagogues.

Faraj M, Lu HL, Cianflone K.

Biochem Cell Biol. 2004 Feb;82(1):170-90. Review.

PMID:
15052336
14.

Does dietary fat influence insulin action?

Storlien LH, Kriketos AD, Jenkins AB, Baur LA, Pan DA, Tapsell LC, Calvert GD.

Ann N Y Acad Sci. 1997 Sep 20;827:287-301. Review.

PMID:
9329762
16.

Visceral obesity: a "civilization syndrome".

Björntorp P.

Obes Res. 1993 May;1(3):206-22. Review.

18.

[Adipocytokins, obesity and development of type 2 diabetes].

Lacquemant C, Vasseur F, Leprêtre F, Froguel P.

Med Sci (Paris). 2005 Dec;21 Spec No:10-8. Review. French.

PMID:
16598899
19.

[And what about diabetes?].

Cerasi E.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):941-3; discussion 943. French.

PMID:
18225448
20.

Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.

Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, Bergman RN.

Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E454-61. Epub 2004 Nov 2.

Supplemental Content

Support Center